TABLE 1.
Meta-analysis of arrhythmia patients’ treatment with Cordyceps.
| Category | n | Participants, n (cases/controls) | Heterogeneity | RR (95%CI) | Z-test |
|---|---|---|---|---|---|
| Ph I2 (%) | |||||
| Effective rate | |||||
| Bradyarrhythmia | 5 | 236/225 | 0.18 37 | 1.24 (1.15–1.35) | z = 5.42; P z <0.00001 |
| Ventricular arrhythmia | 5 | 259/257 | 0.08 51 | 1.27 (1.17–1.39) | z = 5.51; P z <0.00001 |
| Atrial arrhythmia | 4 | 145/145 | 0.36 7 | 1.40 (1.20–1.63) | z = 4.24; P z <0.0001 |
| Multiple types of arrhythmias | 4 | 182/176 | <0.0001 88 | 1.34 (1.19–1.51) | z = 4.75; P z <0.00001 |
| Incidence of disease | |||||
| Ventricular premature beat | 1 | 40/41 | NA NA | 0.34 (0.10–1.17) | z = 1.71; P z = 0.09 |
| Ventricular tachycardia | 1 | 40/41 | NA NA | 1.02 (0.22–4.78) | z = 0.03; P z = 0.97 |
| Ventricular flutter | 1 | 40/41 | NA NA | 0.51 (0.05–5.43) | z = 0.56; P z = 0.58 |
| Ventricular fibrillation | 1 | 40/41 | NA NA | 0.13 (0.02–0.98) | z = 1.98; P z = 0.05 |
P z <0.05 shows a significant association. CI, confidence interval; NA, not available; RR, relative risk; Ph, p-values.